Tapping into new markets for Canadian maple syrup

Apr 12, 2019

Saint-Herménégilde, Québec – Agriculture and Agri-Food Canada - Marie-Claude Bibeau, Minister of Agriculture and Agri-Food, announced an investment of over $2.2 million to help the Maple Syrup Producers of Quebec increase global demand and promote Canadian maple syrup to international markets.

This investment enables the maple syrup sector to expand and diversify exports, and seize opportunities for Canadian maple syrup in existing and emerging markets in the United Kingdom, Germany, Japan and China.

In United Kingdom, advertising and promotion activities will be developed, including new recipes to help raise awareness about maple products. The partnership established with the Royal Academy of Culinary Arts, including renowned chefs, and the academic network will allow the link of maple products and gastronomy. Similar promotional activities will be developed in Germany.

A feasibility study on electronic commerce will be conducted in Japan in order to put an action plan in place. As well, a market research survey will be conducted in China to identify on-line marketing practices and strategies to promote regular consumption of maple products.

Source : Government Of Canada

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.